Deep experience with ctdna and minimally invasive biomarkers
Proven ability to develop decision frameworks for roi
Experience influencing go/no-go and dose selection decisions
**
AstraZeneca is seeking an Executive Director for Multimodal & Minimally Invasive Biomarker Strategy in Canada. The role focuses on establishing enterprise strategy for biomarkers in oncology, particularly ctDNA, while leading a team and fostering cross-functional collaboration.
**
Job Summary
This role is suited for a leader who wants to move beyond individual biomarker strategies and build a more consistent and scalable approach that improves how decisions are made across the oncology portfolio.
The position requires defining an enterprise strategy for minimally invasive and multimodal biomarkers with a specific emphasis on ctDNA across tumor-naïve and tumor-informed approaches.
AstraZeneca offers a workplace culture focused on bold thinking, requiring a minimum of three days per week in the office while balancing individual flexibility.
Matching Summary
Match Score: 75
**
AstraZeneca is seeking an Executive Director for Multimodal & Minimally Invasive Biomarker Strategy in Canada. The role focuses on establishing enterprise strategy for biomarkers in oncology, particularly ctDNA, while leading a team and fostering cross-functional collaboration.
**
Skills & Requirements
Must-have
Deep experience with ctDNA and minimally invasive biomarkers
Proven ability to develop decision frameworks for ROI
Experience influencing go/no-go and dose selection decisions
Track record of building high-performing scientific teams
Executive-level communication skills for governance discussions
Nice-to-have
Experience translating biomarkers into regulated companion diagnostics
Familiarity with FDA, EMA, and PMDA regulatory frameworks
Experience with AI/ML applications in biomarker development
Broad experience across multiple tumor types and therapeutic modalities
External scientific visibility through high-impact publications
Key Requirements
PhD, MD, or MD/PhD in molecular biology, cancer biology, or genomics
15+ years of progressive experience in oncology biomarker development
Demonstrated advancement into senior leadership roles
Experience working in complex matrixed environments without direct authority